ClinicalTrials.Veeva

Menu

Factor XIII and Pulmonary Embolism in Neurosurgical Patients

L

Ludwig Maximilian University of Munich

Status

Unknown

Conditions

Pulmonary Embolism
Vascular Lesion
Brain Tumor
Factor XIII Deficiency

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Two studies (Gerlach et al. 2000; Gerlach et al. 2002) described the impact of factor XIII on the risk of prospective hemorrhage for patients undergoing craniotomy. Since then, factor XIII is measured and substituted in various centers. Few reports support the idea of factor XIII being involved in the formation of deep venous thrombosis and pulmonary embolism. In this prospective observational study, patients undergoing craniotomy for brain tumors or vascular lesions are investigated concerning the incidence of postoperative pulmonary embolism in respect of possible risk factors (factor XIII activity levels, standard coagulation parameters, tumor entity, blood loss).

Enrollment

130 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • preoperatively low Factor XIII activity
  • neurosurgical procedure (craniotomy)
  • substitution of Factor XIII
  • postoperative occurence of pulmonary embolism

Exclusion Criteria:

Trial design

130 participants in 1 patient group

Patients with low Factor XIII
Description:
Postoperative occurence of pulmonary embolism in patients scheduled to undergo a neurosurgical procedure with laboratory-confirmed low levels of Factor XIII

Trial contacts and locations

1

Loading...

Central trial contact

Stefan Grau, Dr.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems